Furthermore, tanshinone IIA (1) ameliorated DSS-induced inflammatory bowel disease (IBD) through the pregnenolone X receptor (PXR)-mediated upregulation of exogenous metabolism and the downregulation of NF-κB signaling [100]. The gene discussed is NR1I2; the disease is inflammatory bowel disease.